Specifically, any patient for whom you prescribed Serostim may be eligible to obtain a cash benefit as part of a $24 million Proposed Settlement. We hope that you will be willing to help us inform your patients that may have taken this drug about this Proposed Settlement.

As you likely know, Serostim is a drug approved by the FDA for the treatment of HIV/AIDS patients with wasting or cachexia, and is clinically proven to increase lean body mass and body weight and improve physical endurance. Serono has also completed two clinical trials for Serostim for use in treating HIV-associated Adipose Redistribution Syndrome (HARS). While Serostim is not yet approved to treat HARS, Serono has an application pending before the FDA for that use.

To qualify for a cash payment, the patient must have paid for all or part of the prescription drug Serostim from July 1, 1995 to December 31, 2006. The heirs of these patients are also eligible for relief.

This Proposed Settlement arose out of a group of Class Action lawsuits filed in Boston, Massachusetts. In the case the Plaintiffs claim that Defendants improperly marketed Serostim. The lawsuits claim that Defendants encouraged doctors to prescribe Serostim based on diagnostic criteria that were not approved by the FDA. The lawsuits also claim that Defendants promoted Serostim for other uses without FDA approval. The lawsuits do not allege that Serostim is dangerous to patient health, or that Serostim is not safe and effective for its approved uses.

The Defendants deny any wrongdoing, and have decided to settle to avoid the expense and uncertainty of litigation.

We mailed you a flyer and the Publication Notice that you can distribute to patients. We are able to reimburse you for any reasonable expenses to inform your patients. Additional copies of these are available at the links below. We hope you will also discuss this Proposed Settlement with any of your patients that have taken Serostim. Thank you for your cooperation.

For more information about this case and Proposed Settlement, click on the “Consumer” link below or call the Claims Administrator at (877) 477-0965.